Tobacco Boosts In-Store Advertising
WASHINGTON-Tobacco companies, which were banned from touting their products on billboards last year, have increased their advertising at point-of-sale locations, such as convenience stores, according to a new study funded by the Robert Wood Johnson Foundation.
WASHINGTONTobacco companies, which were banned from touting their products on billboards last year, have increased their advertising at point-of-sale locations, such as convenience stores, according to a new study funded by the Robert Wood Johnson Foundation.
In-store advertising was present in 80% of the stores visited, an increase of 27% over the display ads present prior to the billboard ban. Exterior advertising was observed at 60% of the stores, an increase of 22%. Tobacco promotions were available at 52% of stores visited after the ban, an increase of 65%.
The shift in advertising expenditure is likely to mean that any intended effect of the billboard advertising banas well as other advertising restrictionswill not be fully realized, said lead researcher Frank Chaloupka, PhD, of the University of Illinois at Chicago.
FDA Approves Encorafenib/Cetuximab Plus mFOLFOX6 for Advanced BRAF V600E+ CRC
December 20th 2024The FDA has granted accelerated approval to encorafenib in combination with cetuximab and mFOLFOX6 for patients with metastatic colorectal cancer with a BRAF V600E mutation, as detected by an FDA-approved test.
